Neurocrine Biosciences
NBIX
NBIX
585 hedge funds and large institutions have $12.9B invested in Neurocrine Biosciences in 2024 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 225 increasing their positions, 208 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
585
Holders Change
+36
Holders Change %
+6.56%
% of All Funds
8.48%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.13%
New
89
Increased
225
Reduced
208
Closed
47
Calls
$88M
Puts
$61.6M
Net Calls
+$26.4M
Net Calls Change
+$16.7M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$116M |
| 2 |
JPMorgan Chase & Co
New York
|
$317M |
| 3 |
PA
Perceptive Advisors
New York
|
$111M |
| 4 |
Invesco
Atlanta,
Georgia
|
$157M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$54M |
